TRIGLYCERIDES - MEDIUM CHAIN, FORMULA

Information current as at: 1 July 2026

The processes outlined in the MSW are not applicable to this medicine. Please contact pbs@health.gov.au or 1800 020 613 for further information.

Legend:

Completed N In progress

Not applicable N Yet to commence

Submission Details

Brand name:: Monogen®
Form and strength:: Please search for and view the medicine's Public Summary Document (PSD) for more information
Submission sponsor:: NUTRICIA AUSTRALIA PTY LIMITED
Condition/indication: (therapeutic use): Dietary management of conditions requiring a source of medium chain triglycerides

Hyperlipoproteinaemia type 1

Long chain fatty acid oxidation disorders

Chylous ascites

Chylothorax
Listing requested:: Please see PSD for more information
Funding program:: Please see PSD for more information
Request authority level:: Please see PSD for more information
PBAC Submission type:: Other business (–)
Comment:: --
Other PBAC consideration:: --

Submission received for:: July 2025 PBAC meeting
Opportunity for consumer comment:: Open 02/04/2025 and close 28/05/2025 (see PBS Website)
PBAC meeting:: Held on 09/07/2025
PBAC outcome published:: Recommended (see PBAC Outcomes)
Notice of intent submitted:: Not Applicable
Lodgement of required documentation:: Not applicable
Agreement to listing arrangements:: Not applicable
Government processes:: Not applicable
Medicine listed on the PBS:: Not applicable

PBAC Recommendation:

Please see the Outcomes from the relevant meeting for more information

Public Summary Document:

Case ID

a1200

Page last updated

30 June 2026

v.9.19